Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer
812.10 18.65 (2.35%)
NSE Aug 16, 2022 11:49 AM
Volume: 32,672

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets
By Ketan Sonalkar


Caplin Point Laboratories is an export-oriented pharmaceutical company that generates its entire revenues through exports. The majority of its revenues comes from the less regulated markets of Latin America, where it has established a strong presence over the last two decades. In recent years, the company has also entered the US market and is planning on expanding its presence there. …

Premium This is a premium article. Click here to read.

Caplin Point Laboratories Ltd. has gained 22.64% in the last 3 Months
More from Caplin Point Laboratories Ltd.
More from Ketan Sonalkar